期刊文献+

影响绝经后妇女骨量的相关因素分析

Analysis of the related factors affecting bone mass in postmenopausal women
原文传递
导出
摘要 目的 探讨影响绝经后妇女骨量的相关因素。方法 记录 14 2名健康绝经后妇女年龄、体重、身高、体重指数、初潮年龄、绝经年龄、初产年龄、分娩次数 ,采用放免法测定血清雌二醇(E2 )、睾酮 (T)、总三碘甲状腺原氨酸 (TT3 )、总甲状腺素 (TT4 )、甲状旁腺素全段 (PTH SP)、降钙素(CT)。双能X光骨密度仪测量腰椎、髋部、前臂骨密度值 (BMD)。各项指标与骨密度值进行直线相关分析和逐步回归分析。结果 在一般状况的各项指标中 ,影响骨量的主要因素为年龄、绝经年龄和体重 ;骨量随E2 、T、CT、TT3 、TT4 水平的下降而减少 ,随PTH水平的减少而增高 ,影响骨量的调钙激素为E2 、TT4 、PTH。结论 绝经后妇女随增龄和血PTH水平上调骨量丢失增加 ,血雌激素、甲状腺素水平及体重对维持骨量有重要作用。 Objective To investigate the factors affecting bone mass,reasons of osteoporosis and related bone metabolic factors in postmenopausal women. Methods The age, weight, height, body mass index (BMI), age of first menstruation, age of menopause, age of first parturition and times of parturition in 142 cases of healthy postmenopausal women were recorded. Levels of estradiol (E 2), testosterone (T),total triiodothyronine(TT 3), total thyroid hormone (TT 4), parathyroid hormone (PTH SP) and calcitonin (CT) in serum were measured by radioimmunoassay.Bone mass density (BMD) at lumbar vertebrae, hip, forearm was measured by dual energy x ray absorptiometry (DEXA).These statistic results were analyzed by SPSS. Results The bone mass was mainly associated with age, age of menstruation, weight;and bone mass was loss with levels of T, E 2, TT 3,TT 4 , CT declined. The main factors affecting bone mass were E 2, TT 4 and PTH .Conclusion The weight and levels of estrogen and thyroid hormone play a significant role to maintain bone mass.
出处 《临床内科杂志》 CAS 北大核心 2002年第3期182-184,共3页 Journal of Clinical Internal Medicine
基金 广西壮族目治区科技厅科学基金资助项目 (科桂回992 0 0 1 9)
关键词 相关因素分析 绝经后 骨质疏松 调钙激素 骨密度 测定 Menopause Osteoporosis Caclicum regulating hormones Bone mass density detect
  • 相关文献

参考文献6

二级参考文献19

  • 1王志清,刘洁.尼尔雌醇防治绝经后骨质疏松症和血脂紊乱的研究进展[J].中国新药杂志,1996,5(5):335-339. 被引量:9
  • 2杨鲁渤,张晓茹,李光明,汤伯基.高血压病患者胰岛素抵抗及其与血小板胞浆钙、甲状旁腺激素的关系[J].标记免疫分析与临床,1996,3(2):96-97. 被引量:2
  • 3周文泉 王巍 等.延缓衰老中药的筛选规程和临床观察规范[J].中西医结合杂志,1986,6(11):682-684.
  • 41,Kinyamu HK,Gallagher JC,Prahl JM,et al.Association between intestinal vitamin D receptor,calcium absorption,and serum 1,25-dihydroxyvitamin D in normal young and elderly women.J Bone Miner Res,1997,12(6):922-928.
  • 52,Gallagher JC,Riggs BL,DeLuca HF.Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.J Clin Endocrinol Metab,1980,51(6):1359-1364.
  • 63,Bikle DD.Role of vitamin D,its metabolites and analogs in the management of osteoporosis.Rheum Dis Clin North Am,1994,20(3):759-775.
  • 74,Heikkinen A,Parviainen MT,Tuppurainen MT,et al.Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.Calcif Tissue Int,1998,62(1):26-30.
  • 85,Cummings SR,Browner WS,Bauer D,et al.Endogenous hormones and the risk of hip and vertebral fractures among older women.Study of Osteoporotic Fractures Research Group.N Engl J Med,1998,339(11):733-738.
  • 96,Van-Hoof HJ,Swinkels LM,Van-Stevenhagen JJ,et al.Advantages of paper chromatography as a preparative step in the assay of 1,25-dihydroxyvitamin D.J Chromatogr,1993,621(1):33-39.
  • 107,Falkenbach A,Sedlmeyer A,Unkelbach U.J Clin Endocrinol metab,1997,82(1):209-212.

共引文献1288

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部